Medbroadcast  Powered by MediResource

 Browse alphabetically
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Atrial Fibrillation
Baby Health
Back Health
Bladder (Overactive)
Brain Health
Childhood Vaccinations
Crohn's & Colitis
Cold and Flu
Cosmetic Procedures
Depression NEW!
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal)
Healthy Skin
High Blood Pressure
Kidney Health
Low Testosterone NEW!
Lung Health
Medications and your Health
Mental Health
Multiple Sclerosis NEW!
Natural and Complementary Therapy
Oral Care
Osteoarthritis of the Knee NEW!
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Stroke Risk Reduction
Weight Management
Workplace Health
Yeast Infection
All health channels

Ask an Expert
Clinical Trials
Find a Specialist
Health features

Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
Cancer > Health Features > Managing Advanced Prostate Cancer > Managing prostate cancer
Cancer overview
Breast cancer
Colorectal cancer
Lung cancer
Prostate cancer
Other cancers
Additional resources
Over 3,000 Canadians are diagnosed with cancer each week. Being well informed can help you fight cancer. Get comprehensive information on the most common types of cancer, including causes, staging, treatment options, and prevention.
Cancer resources
Health features
Health tools
Support groups
Tests and procedures
Related medications
Related conditions
Archived webcasts

Managing Advanced Prostate Cancer

Managing prostate cancer

Managing prostate cancer

A diagnosis of locally advanced or metastatic prostate cancer can be tough to hear.

Advanced prostate cancer is harder to treat than early prostate cancer (cancer that has not spread beyond the prostate). Metastatic prostate cancer (cancer that has spread to lymph nodes and distant organs) and most cases of locally advanced prostate cancer (cancer that has spread to tissues just outside the prostate) cannot be cured. Instead, treatment aims to prolong survival, delay the cancer's progression, relieve symptoms, and improve quality of life.

The good news is that there are treatment options still available, including medication, radiation, and surgery. The treatment chosen depends on many factors:

  • previous treatments you have received
  • where the cancer has recurred
  • whether you have other conditions such as heart disease or diabetes
  • individual considerations

Available treatment options include hormone therapy, radiation therapy, chemotherapy, and surgery.

Hormone therapy

Hormone therapy is used to treat metastatic prostate cancer and some cases of locally advanced prostate cancer. It is used to prolong life, relieve symptoms, delay cancer progression, and improve quality of life. With hormone therapy, medications or surgery are used to reduce the levels of androgens (male hormones such as testosterone), so they cannot cause the tumour to grow. This may be done through surgery to remove the testicles (which produce androgens) or by using medications.

Hormone therapy medications may be given through subcutaneous injection (injection under the skin), subcutaneous depot (a tiny long-acting implant inserted under the skin), intramuscular injection (injection into a muscle), intramuscular depot (long-acting injection into a muscle), orally (by mouth; e.g., tablets), or nasally (into the nose).

Hormone therapy medications include:

  • luteinizing hormone-releasing hormone (LHRH) analogues (which work by blocking androgen production):
    • buserelin nasal (Suprefact®) and subcutaneous (Suprefact®, Suprefact Depot®)
      • usual dose (nasal): two pumps in each nostril three times a day
      • usual dose (subcutaneous): one injection once daily
      • usual dose (subcutaneous depot): one implant every 2 or 3 months
    • goserelin subcutaneous (Zoladex®, Zoladex-LA®)
      • usual dose: one implant (given by subcutaneous injection) every 1 or 3 month
    • leuprolide intramuscular (Lupron®, Lupron Depot®)
      • usual dose (intramuscular): one injection once daily
      • usual dose (intramuscular depot): one injection every 1, 3, or 4 months
    • leuprolide gel subcutaneous (Eligard®)
      • usual dose: one injection every 1, 3, 4, or 6 months
    • triptorelin intramuscular (Trelstar®)
      • usual dose: one injection every 1 or 3 months
  • nonsteroidal anti-androgens (which work by blocking the effects of androgens on the prostate; they are used in combination with LHRH analogues or surgery):
    • bicalutamide tablets (Casodex®, generics)
      • usual dose: 50 mg once daily
    • cyproterone tablets (Androcur®, generics) and intramuscular (Androcur Depot®)
      • usual dose (tablets): 100 mg to 300 mg divided into two or three doses per day
      • usual dose (intramuscular): 300 mg once every one or two weeks
    • flutamide tablets (Euflex®, generics)
      • usual dose: 250 mg three times a day
    • nilutamide tablets (Anandron®)
      • usual dose: 150 mg once daily

Radiation therapy

Radiation therapy uses radiation (a type of energy) to kill cancer cells. It can be given by:

  • external beam
  • brachytherapy (radioactive seed implants inserted through surgery)

For locally advanced prostate cancer, radiation is often used in combination with hormone therapy to slow the spread of the cancer, prolong life, and relieve symptoms. For metastatic prostate cancer, it is used to relieve symptoms and control the spread of the cancer.


Chemotherapy uses medications (usually in combinations called regimens) to kill cancer cells. Chemotherapy is used when advanced prostate cancer stops responding to hormone therapy or when prostate cancer returns. Chemotherapy may be used to prolong life, improve quality of life, and relieve side effects caused by the cancer's spread.

Chemotherapy medications often used to treat advanced prostate cancer include:

  • docetaxel (Taxotere®) - used in combination with prednisone or prednisolone
    • usual dose: one infusion (a slow injection into a vein) every 3 weeks
  • mitoxantrone (generics) - used in combination with prednisone
    • usual dose: one infusion (a slow injection into a vein) every 3 weeks

Chemotherapy medications are usually continued until the cancer progresses or until a maximum dose (determined by the doctor based on your body size) has been reached.


For locally advanced prostate cancer, a transurethral resection of the prostate (also called TURP, a surgery where excess prostate tissue is removed) can help relieve symptoms. In some cases, a radical prostatectomy (a surgery that removes the entire prostate) can even provide a cure.

For metastatic prostate cancer, surgery is used to relieve symptoms of the cancer's spread (e.g., a tumour that is blocking urination) and make a person more comfortable.

Working with your doctor

There are a variety of options for treating advanced prostate cancer. To find the option that's right for you, discuss your treatment options with your doctor. Though all treatments have side effects, it's important to realize that side effects may be preventable, manageable, or reversible. Speak with your doctor about the risks and benefits of each treatment and how you will feel as you receive treatment.

Managing Advanced Prostate Cancer

Managing prostate cancer



Did you find what you were looking for on our website? Please let us know.

Hot Topics - Bedwetting, Depression, Flu (Seasonal), Healthy Skin, Incontinence, Multiple Sclerosis, Psoriasis, Stroke Risk Reduction

Condition and disease information is written and reviewed by the MedBroadcast Clinical Team.

The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2015 MediResource Inc. - MediResource reaches millions of Canadians each year.